Universität Ulm

Running trials

• Recruiting

  Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS

  NCT07322003· Phase 3· Source

• Recruiting

  Disentangling the Effect of Brain Insulin Resistance on Brain Health

  NCT07374705· Source

• Recruiting

  Immunoadsorption for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

  NCT07154524· Source

• Recruiting

  Hypercaloric PEG Nutrition in ALS to Sustain Energy Homeostasis

  NCT06877143· Source

• Active, not recruiting

  Ultra-high-caloric, Fatty Diet in ALS

  NCT06280079· Source

• Active, not recruiting

  A Phase III Randomised Study to Evaluate Dato-DXd and Durvalumab Injections Before and After Surgery for the Treatment of Adult Patients with Breast Cancer

  NCT06112379· Phase 3· Source

• Recruiting

  Immunoadsorption Versus Immunoglobulins for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

  NCT04881682· Phase 2· Source

• Recruiting

  Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients

  NCT03127267· Phase 3· Source

• Recruiting

  Neuroimmunology Registry and Biobank

  NCT06958341· Source

• Recruiting

  Systematic Assessment of Laryngopharyngeal Function in Patients With Neurodegenerative Diseases

  NCT04706234· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• ALS (motor neurone disease)3 recruiting
• CIDP (chronic inflammatory demyelinating polyneuropathy)2 recruiting
• Epilepsy1 recruiting
• Parkinson disease1 recruiting
• Schizophrenia1 recruiting
• Type 1 diabetes1 recruiting
• Type 2 diabetes1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Efficacy and Tolerability of Beta Hydroxybutyrate Ester in Patients With Amyotrophic Lateral Sclerosis (ALS)

  NCT04820478· Source

• Completed

  Verapamil SR in Adults With Type 1 Diabetes

  NCT04545151· Phase 2· Source

• Completed

  A Phase 2 Study to Evaluate Safety of Long-term AL001 Dosing in Frontotemporal Dementia (FTD) Patients (INFRONT-2)

  NCT03987295· Phase 2· Source

• Completed

  Long Term Extension Trial of Setmelanotide

  NCT03651765· Phase 2/3· Source

• Completed

  Gazyvaro and Low Dose Radiotherapy in Early Stage Follicular Lymphoma

  NCT03341520· Phase 2· Source

• Completed

  TRAMmoniTTR Study Genetic Screening of an At-risk Population for hATTR and Monitoring of TTR Positive Subjects

  NCT03237494· Source

• Completed

  Ruxolitinib and Pomalidomide Combination Therapy in Patients With Primary and Secondary MF

  NCT01644110· Phase 1/2· Source

Trial sites

• Department of Neurology, Medical University of Ulm1 trial
• Department of Neurology, University of Ulm2 trials
• Ulm Universita, Department of Neurology1 trial
• Ulm University2 trials
• Universität Ulm1 trial
• University of Ulm9 trials
• University of Ulm, Neurology1 trial

Conditions

Diseases this institution publishes on or runs trials for.

• Type 1 diabetes38 works · 2 trials
• ALS (motor neurone disease)34 works · 5 trials
• Chronic lymphocytic leukaemia19 works · 0 trials
• Frontotemporal dementia15 works · 1 trials
• Huntington's disease13 works · 0 trials
• Pulmonary arterial hypertension13 works · 0 trials
• Long COVID and ME/CFS9 works · 0 trials